abstract |
MONOMERIC PEPTIDE, MULTIMERIC PEPTIDE UNDERSTANDING IT, ITS USE, DIMERIC PEPTIDE, FUSION AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME, AS WELL AS METHODS OF DETECTION OF FcR IN DETECTION AND DETERMINATION OF DETERMINATION OF A DETERMINATION OF A DETERMINATION OF A DETERMINATION OF DETERMINATION OF A DETERMINATION OF DETERMINATION OF A DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION OF DETERMINATION. The present invention relates to peptides that bind to human FcRn and inhibit binding of the Fc portion of an IgG to an FnRn, thereby modulating serum IgG levels. The described compositions and methods can be used, for example, in the treatment of autoimmune diseases and inflammatory disorders. The invention also relates to methods of use and methods of making the peptides of the invention. |